Because the cell line examples may not be typical, we looked for examples of FBXL17 rearrangements in breast cancers, in paired-end whole-genome DNA sequencing data from 250 primary breast tumours of the Cambridge Personalised Breast Cancer Programme. This evidence concerns the gene FBXL17 and breast cancer.